Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo.

Tulunay FC, Karan O, Aydin N, Culcuoglu A, Guvener A.

Cephalalgia. 1987 Jun;7(2):131-3.

PMID:
3301001
2.

Dihydroergotamine nasal spray in the treatment of acute migraine.

Treves TA, Kuritzky A, Hering R, Korczyn AD.

Headache. 1998 Sep;38(8):614-7.

PMID:
11398305
3.

Dihydroergotamine nasal spray for the acute treatment of migraine.

Ziegler D, Ford R, Kriegler J, Gallagher RM, Peroutka S, Hammerstad J, Saper J, Hoffert M, Vogel B, Holtz N, et al.

Neurology. 1994 Mar;44(3 Pt 1):447-53.

PMID:
8145914
4.

A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.

Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A.

Neurology. 1996 Aug;47(2):361-5.

PMID:
8757005
6.
7.
8.

[Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance].

Jenzer G, Bremgartner MF.

Schweiz Rundsch Med Prax. 1990 Aug 2;79(31-32):914-7. German.

PMID:
2203127
9.

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.

Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(11):839-51.

PMID:
12921494
10.

A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.

Boureau F, Kappos L, Schoenen J, Esperanca P, Ashford E.

Int J Clin Pract. 2000 Jun;54(5):281-6.

PMID:
10954953
11.

Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.

Derry CJ, Derry S, Moore RA.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD009663. doi: 10.1002/14651858.CD009663. Review.

12.

A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.

Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.

Headache. 2009 Jun;49(6):826-37. doi: 10.1111/j.1526-4610.2009.01453.x.

PMID:
19545249
13.

Efficacy of zolmitriptan nasal spray in adolescent migraine.

Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee..

Pediatrics. 2007 Aug;120(2):390-6.

PMID:
17671066
14.

[Migraine: dihydroergotamine nasal spray--an alternative].

Beubler E.

Wien Med Wochenschr. 1995;145(14):326-31. Review. German.

PMID:
7483646
15.

MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.

Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW.

Headache. 2011 Apr;51(4):507-17. doi: 10.1111/j.1526-4610.2011.01869.x.

PMID:
21457235
16.

Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis. A double-blind, placebo-controlled crossover study.

Bousser MG, Chick J, Fuseau E, Soisson T, Thevenet R.

Cephalalgia. 1988 Sep;8(3):187-92.

PMID:
3197098
17.
18.
19.

Dihydroergotamine: role in the treatment of migraine.

Schürks M.

Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1141-8. doi: 10.1517/17425250903164211. Review.

PMID:
19624283
20.

Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.

Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M.

Arch Fam Med. 1998 May-Jun;7(3):234-40.

PMID:
9596457

Supplemental Content

Support Center